These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19374997)

  • 21. Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
    Suda S; Westerbeek A; O'Connor PM; Ross RP; Hill C; Cotter PD
    Chem Biol; 2010 Oct; 17(10):1151-60. PubMed ID: 21035738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lantibiotics: structure, biosynthesis and mode of action.
    McAuliffe O; Ross RP; Hill C
    FEMS Microbiol Rev; 2001 May; 25(3):285-308. PubMed ID: 11348686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of lantibiotic synthetases for the preparation of bioactive constrained peptides.
    Levengood MR; van der Donk WA
    Bioorg Med Chem Lett; 2008 May; 18(10):3025-8. PubMed ID: 18294843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges.
    van den Hooven HW; Lagerwerf FM; Heerma W; Haverkamp J; Piard JC; Hilbers CW; Siezen RJ; Kuipers OP; Rollema HS
    FEBS Lett; 1996 Aug; 391(3):317-22. PubMed ID: 8764998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome.
    Lai KY; Galan SRG; Zeng Y; Zhou TH; He C; Raj R; Riedl J; Liu S; Chooi KP; Garg N; Zeng M; Jones LH; Hutchings GJ; Mohammed S; Nair SK; Chen J; Davis BG; van der Donk WA
    Cell; 2021 May; 184(10):2680-2695.e26. PubMed ID: 33932340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the evolution of lanthipeptide biosynthesis.
    Yu Y; Zhang Q; van der Donk WA
    Protein Sci; 2013 Nov; 22(11):1478-89. PubMed ID: 24038659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB.
    Ortega MA; Hao Y; Zhang Q; Walker MC; van der Donk WA; Nair SK
    Nature; 2015 Jan; 517(7535):509-12. PubMed ID: 25363770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
    Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic studies on the substrate-tolerant lanthipeptide synthetase ProcM.
    Mukherjee S; van der Donk WA
    J Am Chem Soc; 2014 Jul; 136(29):10450-9. PubMed ID: 24972336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Enzymology of Prochlorosin Biosynthesis.
    Bobeica SC; van der Donk WA
    Methods Enzymol; 2018; 604():165-203. PubMed ID: 29779652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic.
    Huo L; van der Donk WA
    J Am Chem Soc; 2016 Apr; 138(16):5254-7. PubMed ID: 27074593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lantibiotics: mode of action, biosynthesis and bioengineering.
    Bierbaum G; Sahl HG
    Curr Pharm Biotechnol; 2009 Jan; 10(1):2-18. PubMed ID: 19149587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
    Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
    Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lantibiotics: peptides of diverse structure and function.
    Willey JM; van der Donk WA
    Annu Rev Microbiol; 2007; 61():477-501. PubMed ID: 17506681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide backbone modifications in lanthipeptides.
    Ayikpoe RS; van der Donk WA
    Methods Enzymol; 2021; 656():573-621. PubMed ID: 34325799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic Studies on Dehydration in Class V Lanthipeptides.
    Liang H; Lopez IJ; Sánchez-Hidalgo M; Genilloud O; van der Donk WA
    ACS Chem Biol; 2022 Sep; 17(9):2519-2527. PubMed ID: 36044589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodologies and strategies for the bioengineering of lantibiotics.
    Nagao J; Nishie M; Sonomot K
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1221-30. PubMed ID: 21470152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
    Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
    Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
    Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG
    Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.